Literature DB >> 12428094

Hemophilia A mutations within the factor VIII A2-A3 subunit interface destabilize factor VIIIa and cause one-stage/two-stage activity discrepancy.

William H Hakeos1, Hongzhi Miao, Nongnuch Sirachainan, Geoffrey Kemball-Cook, Evgueni L Saenko, Randal J Kaufman, Steven W Pipe.   

Abstract

Thrombin-activated factor VIII (FVIIIa) is a heterotrimer with the A2 subunit in a weak ionic interaction with the A1 and A3-C1-C2 subunits. Dissociation of the A2 subunit correlates with inactivation of FVIIIa. A homology model (Blood 89:2413, 1997) of the triplicated A domains of factor VIII (FVIII) predicts a pseudo-threefold axis at the tightly packed hydrophobic core with several interdomain interactions. These lie at the interface of A1-A2, A2-A3 and A1-A3. We have previously demonstrated that hemophilia A mutations (R531H, A284E, S289L) within the predicted A1-A2 and A1-A3 interface disrupt potential intersubunit hydrogen bonds and have the molecular phenotype of increased rate of inactivation of FVIIIa due to increased rate of A2 subunit dissociation. Patients with these mutations exhibit a clinical phenotype where the FVIII activity by one-stage(1-st) assay is at least two-fold higher than by two-stage(2-st) assay. We have now also explored mutations within the predicted A2-A3 interface (N694I, R698W and R698L) that also have the phenotype of 1-st/2-st activity discrepancy. These mutations exhibit the same molecular mechanism of increased instability of FVIIIa as those mutations described along the A1-A2 and A1-A3 interfaces. This suggests that the entire tightly packed hydrophobic core within the predicted pseudo-threefold axis contributes to stabilization of FVIIIa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428094

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.

Authors:  Ernest T Parker; Pete Lollar
Journal:  Biochemistry       Date:  2007-08-04       Impact factor: 3.162

2.  Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

3.  Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.

Authors:  M Monaghan; H Wakabayashi; A E Griffiths; P J Fay
Journal:  J Thromb Haemost       Date:  2016-03-21       Impact factor: 5.824

4.  Increasing hydrophobicity or disulfide bridging at the factor VIII A1 and C2 domain interface enhances procofactor stability.

Authors:  Hironao Wakabayashi; Amy E Griffiths; Philip J Fay
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

5.  Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII.

Authors:  Wei Wei; Saurav Misra; Matthew V Cannon; Renchi Yang; Xiaofan Zhu; Reid Gilmore; Min Zhu; Bin Zhang
Journal:  Biochem J       Date:  2018-03-06       Impact factor: 3.857

6.  Enhanced factor VIIIa stability of A2 domain interface variants results from an increased apparent affinity for the A2 subunit. Results from an increased apparent affinity for the A2 subunit.

Authors:  M Monaghan; H Wakabayashi; A Griffiths; J Wintermute; P J Fay
Journal:  Thromb Haemost       Date:  2014-06-05       Impact factor: 5.249

7.  Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface.

Authors:  Hironao Wakabayashi; Fatbardha Varfaj; Jennifer Deangelis; Philip J Fay
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

8.  Combining mutations of charged residues at the A2 domain interface enhances factor VIII stability over single point mutations.

Authors:  H Wakabayashi; A E Griffiths; P J Fay
Journal:  J Thromb Haemost       Date:  2008-12-04       Impact factor: 5.824

9.  Activated protein C has a regulatory role in factor VIII function.

Authors:  Amelia R Wilhelm; Nicole A Parsons; Benjamin J Samelson-Jones; Robert J Davidson; Charles T Esmon; Rodney M Camire; Lindsey A George
Journal:  Blood       Date:  2021-05-06       Impact factor: 22.113

10.  Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.

Authors:  Wei Wei; Chunlei Zheng; Min Zhu; Xiaofan Zhu; Renchi Yang; Saurav Misra; Bin Zhang
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.